X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (120) 120
female (85) 85
male (74) 74
humans (73) 73
rats (67) 67
naphthalenesulfonates - administration & dosage (54) 54
index medicus (52) 52
naphthalenesulfonates - pharmacology (44) 44
mice (36) 36
polymers - administration & dosage (31) 31
dose-response relationship, drug (29) 29
hiv infections - prevention & control (24) 24
naphthalenesulfonates - toxicity (23) 23
pharmacology & pharmacy (23) 23
administration, intravaginal (22) 22
naphthalenesulfonates - metabolism (22) 22
azo compounds - toxicity (20) 20
infectious diseases (20) 20
time factors (20) 20
adult (18) 18
naphthalenesulfonates - adverse effects (18) 18
naphthalenesulfonates - therapeutic use (17) 17
spectrometry, fluorescence (17) 17
biochemistry & molecular biology (16) 16
hiv (16) 16
pregnancy (16) 16
anilino naphthalenesulfonates - chemistry (15) 15
body weight - drug effects (15) 15
immunology (15) 15
kinetics (15) 15
naphthalenesulfonates (15) 15
rats, inbred strains (15) 15
toxicology (15) 15
transmission (15) 15
naphthalenesulfonates - chemistry (14) 14
prevention (14) 14
adolescent (13) 13
anti-infective agents (13) 13
gels (13) 13
protein binding (13) 13
food coloring agents - toxicity (12) 12
anilino naphthalenesulfonates (11) 11
fluorescence (11) 11
hydrogen-ion concentration (11) 11
infection (11) 11
liver - metabolism (11) 11
middle aged (11) 11
polymers - adverse effects (11) 11
proteins (11) 11
women (11) 11
administration, oral (10) 10
cell line (10) 10
virology (10) 10
analysis (9) 9
anti-infective agents - administration & dosage (9) 9
anti-infective agents, local - administration & dosage (9) 9
article (9) 9
azo compounds - metabolism (9) 9
azo compounds - pharmacology (9) 9
health aspects (9) 9
infections (9) 9
liver - drug effects (9) 9
naphthalenesulfonates - pharmacokinetics (9) 9
anti-hiv agents - administration & dosage (8) 8
antiviral agents - administration & dosage (8) 8
aspartic acid - analogs & derivatives (8) 8
aspartic acid - pharmacology (8) 8
azo compounds - administration & dosage (8) 8
cells (8) 8
coloring agents - pharmacology (8) 8
disease models, animal (8) 8
feces - analysis (8) 8
fluorescent dyes (8) 8
food coloring agents - metabolism (8) 8
food science & technology (8) 8
hiv-1 - drug effects (8) 8
human immunodeficiency virus--hiv (8) 8
in-vivo (8) 8
mice, inbred balb c (8) 8
polymers - pharmacology (8) 8
polymers - therapeutic use (8) 8
treatment outcome (8) 8
cancer (7) 7
coloring agents - toxicity (7) 7
diet (7) 7
double-blind method (7) 7
fluorescent dyes - chemistry (7) 7
hiv-1 (7) 7
ligands (7) 7
medicine (7) 7
nonoxynol-9 (7) 7
protein denaturation (7) 7
rabbits (7) 7
rats, wistar (7) 7
research (7) 7
safety (7) 7
acrylic resins - administration & dosage (6) 6
administration, topical (6) 6
anti-hiv agents - pharmacology (6) 6
binding (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AIDS, ISSN 0269-9370, 04/2011, Volume 25, Issue 7, pp. 957 - 966
Journal Article
AIDS, ISSN 0269-9370, 02/2007, Volume 21, Issue 4, pp. 467 - 476
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9749, pp. 1329 - 1337
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2011, Volume 6, Issue 11, p. e27675
Background: Despite significant protection in preclinical studies, cellulose sulfate (CS) failed to protect women against HIV-1/2 and was associated with a... 
IN-VITRO | TRANSMISSION | HIV-INFECTION | HERPES | MULTIDISCIPLINARY SCIENCES | FEMALE SEX WORKERS | NONOXYNOL-9 VAGINAL GEL | PREVENTION | DEFENSIN GENE-CLUSTER | RANDOMIZED CONTROLLED-TRIAL | CELLULOSE SULFATE GEL | Polymers - administration & dosage | Naphthalenesulfonates - therapeutic use | Anti-Infective Agents - adverse effects | Cellulose - therapeutic use | Anti-Infective Agents - therapeutic use | Administration, Intravaginal | Vaginal Creams, Foams, and Jellies - adverse effects | Cellulose - administration & dosage | Vaginal Creams, Foams, and Jellies - therapeutic use | Polymers - therapeutic use | Animals | Anti-Infective Agents - administration & dosage | Herpes Genitalis - prevention & control | Naphthalenesulfonates - administration & dosage | Female | Naphthalenesulfonates - adverse effects | Mice | Vaginal Creams, Foams, and Jellies - administration & dosage | Cellulose - adverse effects | Polymers - adverse effects | Herpesvirus 2, Human - drug effects | Herpesvirus 2, Human - pathogenicity | Cellulose - analogs & derivatives | Cellulose | Medroxyprogesterone | Anti-infective agents | Product development | Disease susceptibility | HIV (Viruses) | Sulfates | Health aspects | Risk factors | Pediatrics | Plasma | Animal models | Sexually transmitted diseases--STD | Toxicity | Pathogenesis | Genes | Herpes simplex | Clinical trials | Viruses | Infections | Inoculation | Immunology | Acquired immune deficiency syndrome--AIDS | Rodents | Human immunodeficiency virus--HIV | Safety | Product safety | Drug dosages | Formulations | Pathogens | Medical research | Effectiveness | Gels | Architecture | Semen | Vagina | Bioavailability | Nonoxynol | Medicine | Disease prevention | Herpes viruses | Conditioned stimulus | Sulfate | STD | Sexually transmitted diseases | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2009, Volume 14, Issue 8, pp. 1113 - 1124
Journal Article
Journal Article
Journal Article
Journal Article
Comparative Biochemistry and Physiology, Part C, ISSN 1532-0456, 01/2015, Volume 167, pp. 108 - 116
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 08/2014, Volume 90, Issue 5, pp. 363 - 369
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 7/2015, Volume 23, Issue 7, pp. 2045 - 2051
The aim of this study was to compare the effectiveness of prophylactic single fixed dose of pegfilgrastim and daily administration of filgrastim on febrile... 
Greece | Pain Medicine | Nursing | Rehabilitation Medicine | Medicine & Public Health | Oncology | Breast cancer | Neulasta | Dose-dense chemotherapy | Nursing Management/Nursing Research | Neutropenia | COST-EFFECTIVENESS | COOPERATIVE ONCOLOGY GROUP | COLONY-STIMULATING FACTOR | SOLID TUMORS | RECEIVING CHEMOTHERAPY | PHASE-III | PRIMARY PROPHYLAXIS | ONCOLOGY | FEBRILE NEUTROPENIA | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | DENSE SEQUENTIAL CHEMOTHERAPY | QUALITY-OF-LIFE | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Drug Administration Schedule | Peptides | Polyethylene Glycols | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Chemotherapy-Induced Febrile Neutropenia - prevention & control | Breast Neoplasms - drug therapy | Filgrastim | Recombinant Proteins - administration & dosage | Randomized Controlled Trials as Topic | Breast Neoplasms - blood | Observational Studies as Topic | Female | Retrospective Studies | Chemotherapy, Adjuvant | Naphthalenesulfonates | Cohort Studies | Granulocyte Colony-Stimulating Factor - administration & dosage | Care and treatment | Cancer patients | Granulocyte colony-stimulating factor | Adjuvant treatment | Comparative analysis | Cancer | Comparative studies | Chemotherapy | Preventive medicine | Drug dosages
Journal Article